Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-11-04Clinical Trial Update: Trial Study of the Efficacy of Intensive Preoperative Pelvic Floor Muscle Training to Decrease Post-prostatectomy Urinary Incontinence [NA]
This clinical trial, sponsored by Queen Mary Hospital in Hong Kong, evaluates whether intensive preoperative pelvic floor muscle training ca…
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases [Phase 3]
Phase 3 trial evaluating zoledronate to prevent skeletal-related events in men with metastatic prostate cancer on androgen deprivation thera…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial of genomic-guided therapy with dasatinib or nilutamide in metastatic castration-resistant prostate cancer has been terminated.…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Phase II Study of ASP3550 in Patients With Prostate Cancer [Phase 2]
This document notes the completion of a Phase II study of ASP3550 in patients with prostate cancer.
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC) [Phase 2]
This Phase 2 trial evaluates whether Acetyl-L-Carnitine can prevent Sagopilone-induced neurotoxicity in prostate and ovarian cancer patients…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer [Phase 2]
Phase 2 trial of bicalutamide in combination with RO4929097 for previously treated prostate cancer was terminated; results were posted in 20…
-
CLINICAL_TRIALS withdrawal · 2014-10-23Clinical Trial Update: 18-F-Fluoroacetate as PET Imaging Agent [Phase 1]
A Phase 1 trial of the PET imaging agent 18-F-Fluoroacetate sponsored by MD Anderson Cancer Center was withdrawn, with conditions including …
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: Assessment of HIFU-induced Prostate Necrosis With Shear-wave Ultrasound Elastography [NA]
A completed clinical trial evaluated HIFU-induced prostate tissue necrosis using shear-wave elastography to assess treatment effects after h…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer [Phase 3]
Phase 3 trial investigating safety and efficacy of oral MDV3100 in chemotherapy-naive patients with progressive metastatic prostate cancer h…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer
This document reports on a completed prospective multicentre non-interventional study evaluating VANTAS for advanced prostate cancer.
-
CLINICAL_TRIALS research · 2014-10-16Clinical Trial Update: Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial assessing the impact of tomato-soy juice on biomarker changes in patients with prostate cancer undergoing …
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men [Phase 1]
Phase 1 study evaluating whether rifampin, a liver enzyme inducer, alters the metabolism of enzalutamide in men to assess potential drug-dru…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer [Phase 1, Phase 2]
This clinical trial update reports termination of a Phase 1/2 study of temsirolimus intended to reverse androgen insensitivity in castration…
-
FDA approval · 2014-10-10FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from URONOVA Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer [Phase 1, Phase 2]
A combined Phase 1/2 clinical trial investigating Taxotere (docetaxel) and Doxil (liposomal doxorubicin) for advanced androgen-independent p…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Lung Function After Robot-assisted Radical Prostate Ectomy [NA]
A completed clinical trial evaluating postoperative lung function after robot-assisted radical prostatectomy. The study involved patients wi…
-
CLINICAL_TRIALS trial_result · 2014-10-08Clinical Trial Update: Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate [Phase 1]
Phase 1 trial evaluating green tea catechins in patients with prostate cancer undergoing prostatectomy has completed. The study targeted men…
-
FDA approval · 2014-10-07FDA Approved: ZOLADEX — Supplemental Application (TerSera Therapeutics LLC)
The FDA approved a supplemental application for ZOLADEX (goserelin) filed by TerSera Therapeutics LLC. This action typically updates labelin…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule [Phase 3]
Phase 3 trial comparing intensity-modulated radiotherapy versus conformal radiotherapy for hypofractionated treatment of prostate cancer has…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]
Phase 2 trial evaluating saracatinib (AZD0530) in hormone-resistant/recurrent prostate cancer has completed, with results posted in 2014.
-
CLINICAL_TRIALS research · 2014-10-03Clinical Trial Update: Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences
Clinical trial update on seed movement in prostate brachytherapy implants and its dosimetric consequences. The study reports clinical measur…
-
CLINICAL_TRIALS research · 2014-09-18Clinical Trial Update: Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer [Phase 2]
A Phase 2 safety trial evaluating pelvic and prostatic SIB-IMRT with long-term androgen deprivation in high-risk localized prostate cancer h…
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer [Phase 2]
Phase 2 trial comparing gabapentin to venlafaxine for hot flashes in prostate cancer patients; study terminated with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer [Phase 2]
Phase 2 two-arm trial evaluating a DNA vaccine encoding PAP in non-metastatic castration-resistant prostate cancer has completed with result…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer [NA]
This completed clinical trial evaluated diffusion-weighted MRI for staging localized prostate cancer.